THE ARISING · DAILY EDITION
The Arising — October 11, 2026
Download the PDF ↓Longevity & Healthspan
First Human Data on Cell-Rejuvenating Gene Therapy Show It Was Well Tolerated, With Early Vision Gains in Glaucoma
A gene therapy designed to turn back the clock on aging cells has now been given to people, and in the first three patients it was well tolerated.
Brain health →Gut Bacteria Compound ImP Linked to Higher Alzheimer's Risk and Faster Cognitive Decline
A molecule made by bacteria in the gut may be tied to how fast the brain ages. In a study of 1,196 adults with no cognitive impairment, people with higher blood levels of imidazole propionate, or ImP, scored lower on memory and thinking tests and showed more blood markers linked to Alzheimer's disease.
Brain health →Menopause Leaves a Blood Protein Signature Linked to Brain Aging and Dementia Risk
Menopause leaves a measurable pattern in the blood, and that pattern lines up with how the brain ages and with dementia risk later in life, according to a new study in Nature Medicine.
Brain health →Hidden Artery Plaque Found in More Than Half of Healthy Adults, Including 1 in 13 Under 30
Artery plaque was found in 57.1% of adults who had no known heart disease, and it was present in the youngest group studied, aged 18 to 29, according to a large study in The New England Journal of Medicine.
Brain health →Ultra-Processed Meals Linked to Higher Insulin, and Food Images to Different Brain Reward Responses, Even When Nutrients Match
Two meals can match on calories, carbohydrates, fat, protein, water and salt, and the body can still respond to them differently. That is the central finding of a new Virginia Tech study in Nature Metabolism, and it challenges the idea that a nutrition label tells the whole story.
Brain health →Foundation Reports First Human Doses of Partial Epigenetic Reprogramming Gene Therapy, Given Outside Formal Trials
A small group of people has reportedly received a gene therapy meant to make aged cells behave younger, and it was done outside any formal clinical trial. That is a milestone for the field, but it is not evidence that the treatment works.
Brain health →A Year of Remote Exercise Slowed Biological Aging in Breast Cancer Survivors
Breast cancer survivors who followed a year-long exercise program delivered remotely showed slower biological aging in their blood than survivors in a comparison wellness program, according to a new randomized trial analysis.
Strength and function →Semaglutide Extends Lifespan in Older Mice, Outperforming Calorie Restriction on Some Measures
A weight-loss drug started late in life helped old mice live longer, and it did some things that eating less did not. That is the finding of a new study in Nature on semaglutide, the drug sold as Ozempic and Wegovy.
GLP-1 medicines →
Markets & Strategy
Lilly and Novo Report GLP-1 Drugs Reduced Biological Age on Molecular Aging Clocks
Two of the world's biggest drugmakers say their weight-loss drugs slow the molecular clocks used to estimate biological age. The claim matters commercially only if those clocks mean what the companies say they mean, and the science behind the clocks is the place to test that.
GLP-1 medicines →FDA Adds Aging and Longevity to Its Regulatory Science Agenda and Outlines Possible Approval Routes
Senior FDA officials said this month that aging and longevity will appear in the agency's next regulatory science agenda. That gives companies working on aging therapies a clearer signal about how the agency is thinking, though it is not yet a path to approval.
Reading medical evidence →Life Biosciences Reports First Human Data for Cellular Reprogramming Drug ER-100 in Glaucoma
Life Biosciences says the first three people to receive its cellular reprogramming drug ER-100 tolerated it through Day 56, and two of them showed early gains on a standard vision test, according to the company's October 8, 2026 press release.
Reading medical evidence →U.S. Nursing Home Operating Capacity Fell 5% Since 2019, Twice the Drop in Licensed Beds, Study Finds
The part of the U.S. nursing home sector that matters most for patients is shrinking faster than the official bed count suggests. A new study in JAMA Internal Medicine finds that operating capacity at skilled nursing facilities fell 5.0% between 2019 and 2024, twice the 2.5% drop in licensed beds.
Care and connection →Manulife Closes $3.2 Billion Long-Term Care Reinsurance Deal With Munich Re
Manulife has handed a large slice of its long-term care risk to Munich Re, and it did so without giving up a single asset.
Care and connection →Prestigious Nonprofit Health Systems Move Into Cash-Pay Longevity Clinics, With One Northwestern-Affiliated Package at $5,500 a Year
Some of the nation's most prestigious hospital systems are now selling longevity checkups, and one of them costs $5,500 a year.
Care and connection →